Duality Advisers’s Health Catalyst HCAT Stock Holding History

Duality Advisers’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-50,833	Closed	-$1.33M	–	703
2022 Q1	$1.33M	Buy	50,833 +8,466	+20%	+$240K	0.14%	260
2021 Q4	$1.68M	Buy	+42,367	New	+$1.93M	0.18%	205
2021 Q1	–	Sell	-14,007	Closed	-$610K	–	601
2020 Q4	$610K	Buy	+14,007	New	+$517K	0.05%	423

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Duality Advisers's HCAT Position: Q2 2022 in Review

Duality Advisers sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 50,833 shares — an estimated $1.33M sold.

Duality Advisers first reported a position in HCAT in Q4 2020 and held it in 3 quarters. The position peaked at $1.68M in Q4 2021. 179 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

Duality Advisers reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
Duality Advisers sold 50,833 Health Catalyst shares in Q2 2022, an estimated $1.33M.
Duality Advisers first reported a position in Health Catalyst in Q4 2020 and held it in 3 quarters.
Duality Advisers's Health Catalyst position peaked at $1.68M in Q4 2021.
179 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Duality Advisers's 13F filing for Q2 2022, filed 8 Aug 2022.